Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » Guidance to help increase production of safe medical supplies

    Guidance to help increase production of safe medical supplies

    npsnps31 March 2020Updated:25 June 2024
    — Filed under: EU News Headline2 Health
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Guidance to help increase production of safe medical supplies

    Protective equipment

    (BRUSSELS) – The EU Commission issued guidance Monday to assist manufacturers in ramping up production of essential medical equipment and material such as personal protective equipment, hand sanitizers and 3D printing.

    A guidance on medical devices will also be made available within the coming days. These documents also aim to assist manufacturers and market surveillance authorities in making sure these products comply with necessary safety standards and are effective.

    The coronavirus outbreak requires support and collaboration from manufacturers. Companies have expressed solidarity and offered to provide practical and technical advice to each other to support increasing the production of PPE and medical supplies. The Commission says it is actively working with industry to promote the massive ramp-up of overall production of such material in the EU and is providing the necessary guidance to facilitate this.

    The communication today outline guidance on three fronts:

    • The first guidance helps manufacturers to assess the applicable legal and technical requirements before importing new products to the EU or launching new or reconverting existing facilities to produce protective equipment like masks, gloves and surgical gowns to satisfy the unprecedented demand in the wake of the coronavirus outbreak.The guidance issued today details the applicable EU legal frameworks and offers manufacturers’ advice on the concrete steps to take in order to be able to place their products on the EU market. It also explains the role of national authorities, in particular market surveillance authorities in ensuring an adequate level of health and safety of equipment originating in third-countries, which is placed on the EU market.
    • The second document intends to provide guidance to economic operators including small and medium-sized enterprises on the applicable legal framework for the placing on the EU market of hydro-alcoholic gel (i.e. the Cosmetic Products Regulation or the Biocidal Products Regulation) and the claims which can be made to the user. It aims at responding to frequent questions the Commission is receiving from operators of the cosmetic and of other sectors, which are heavily engaged in increasing or converting their production capacity towards these products.
    • The third gives guidance on conformity assessment procedures for 3D printing and 3D printed products for medical use in the context of the coronavirus outbreak. The document aims to detail the applicable EU legal frameworks for those products and sets out examples of technical standards which manufacturers may use in order to place compliant products on the EU market.

    The documents offer practical advice on the application of the Commission’s recommendation on conformity assessments of PPE, and certain types of medical devices, issued on 13 March. This recommendation provides for two scenarios in which products may be placed on the market even if the conformity assessment procedures have not yet been finalised.

    They also provides more information on the relevant standards for PPE and certain types of Medical devices that have been made freely available to all economic operators by the European standardisation organisations, thanks to an agreement with the European Commission on 20 March.

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    nps
    • Website

    Related Content

    EMBL logo

    Strategy Officer, European Molecular Biology Laboratory, EMBL

    Fitto - Mînzatu - Photo © European Union 2026

    EUR 34.6 bn cohesion funds reallocated to EU’s strategic priorities

    Health research - Photo by National Cancer Institute on Unsplash

    Brussels awards EUR 617m to doctoral programmes

    Trade port cargo - Image by Pexels from Pixabay

    EU trade in goods with Australia in 2025

    Online teaching call centre - Photo by MART PRODUCTION on Pexels

    Why Europe’s AI Translation Boom Still Needs a Human in the Loop in 2026

    Business finance - Image by Credit Commerce from Pixabay

    UK Lenders Unite with £11 Billion Boost to Support British Businesses

    LATEST EU NEWS
    Fitto - Mînzatu - Photo © European Union 2026

    EUR 34.6 bn cohesion funds reallocated to EU’s strategic priorities

    25 March 2026
    Health research - Photo by National Cancer Institute on Unsplash

    Brussels awards EUR 617m to doctoral programmes

    25 March 2026
    Trade port cargo - Image by Pexels from Pixabay

    EU trade in goods with Australia in 2025

    25 March 2026
    Sefcovic - von der Leyen - Albanese - Photo © European Union 2026

    EU and Australia conclude talks on trade agreement

    24 March 2026
    Putin - Image by svklimkin from Pixabay

    Brussels renews support for exiled and relocated journalists in the EU

    23 March 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?